Hearing Loss Diagnostic Devices Market Size to Witness Impressive Growth
The National Institute on Deafness and Other Communication Disorders (NIH) has reported alarming statistics, revealing that one out of eight people aged 12 and above in the United States suffers from bilateral hearing loss. Furthermore, approximately 2% of the adult population in the country experiences disabling hearing loss, a condition that becomes more prevalent with age. Additionally, three out of every 1,000 children in the US are born with detectable hearing loss in at least one ear, emphasizing the need for early intervention.
These concerning statistics underscore the escalating need for hearing loss diagnostics. The global hearing loss diagnostic devices market is poised for significant growth, driven by the increasing adoption of these devices for evaluating and testing hearing loss in both children and adults.
Rising Prevalence of Hearing Conditions Drives Demand
The World Health Organization (WHO) predicts that nearly 900 million individuals worldwide will be affected by hearing loss by 2050. The growing prevalence of various hearing conditions and hereditary disorders is a key driver of demand for hearing loss diagnostic devices. Factors such as increasing noise pollution, a growing elderly population, and the rising consumption of non-steroidal anti-inflammatory drugs (NSAIDs) and other ototoxic medications are expected to significantly boost the sales of hearing loss diagnostic devices. Additionally, birth-related complications continue to contribute to the expansion of the hearing loss diagnostic devices market.
Untapped Opportunities in Under-recognition and Under-diagnosis
Hearing loss is often under-recognized, and when it is identified, it is frequently addressed solely with hearing enhancement technologies like hearing aids, which are often underused. Many individuals with hearing loss self-identify their condition, while others rely on family members who notice behavioral changes after hearing loss occurs. Despite various screening methods for hearing loss, none offer a comprehensive set of advantages. This is where the importance of in-office testing and diagnosis becomes evident, driving the adoption of hearing loss diagnostic devices.
Audiometry, including whispered voice tests, remains a widely recommended method for diagnosing hearing loss. Diagnostic examinations help screen for abnormalities of the tympanic membrane and external canal. Neurologic examinations are also recommended for conditions such as exostoses and cerumen impaction. Screening for sudden sensorineural hearing loss often requires otolaryngology devices, as well as advanced equipment like computed tomography (CT) scanners and magnetic resonance imaging (MRI) instruments.
Challenges in Affordable Audiological Care
While substantial investments continue to flow into the healthcare sector, affordability remains a challenge in the diagnosis and treatment of hearing loss. The cost of diagnostic equipment remains a major hindrance to the rapid expansion of the hearing loss diagnostic devices market, particularly in cost-sensitive low- and middle-income countries (LMICs). Despite increasing awareness and government support in Western countries, the relative unaffordability of these devices continues to limit market growth.
Key Competitors in the Hearing Loss Diagnostic Devices Market
Leading companies in the hearing loss diagnostic devices sector are focusing on innovation and strategic collaborations to enhance their portfolios. Key players in this market include Inventis, Natus Medical, William Demant, Amplivox, and Maico Diagnostics. Notable recent developments in the global hearing loss diagnostic devices market include:
- In January 2020, Inventis announced its acquisition of Synapsys SAS to enhance its portfolio, particularly in the balance diagnostic segment.
- In February 2020, Natus Medical Incorporated collaborated with ReSound to expand the market reach of Otoscan, positioning it as a routine digital hearing loss diagnostic device.
- In October 2020, Starkey Hearing Technologies and OrCam Technologies partnered to develop assistive technology for individuals with visual impairment and hearing loss.
The hearing loss diagnostic devices market is poised for substantial growth as it addresses the pressing need for early detection and intervention in hearing-related conditions. However, affordability remains a challenge that industry players are working to overcome, particularly in emerging markets.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/hearing-loss-diagnostic-devices-market
Visit Our Blogs:
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad